2017 |
Functional Expression of P-glycoprotein and Organic Anion Transporting Polypeptides at the Blood-Brain Barrier: Understanding Transport Mechanisms for Improved CNS Drug Delivery? |
Thomas P Davis, PhD, Patrick T Ronaldson, PhD, FAAPS |
2017 |
Living GenoChemetics by hyphenating synthetic biology and synthetic chemistry in vivo |
Christopher Cartmell |
2017 |
Emerging Roles of Transforming Growth Factor β Signaling in Diabetic Retinopathy. |
Nam Lee, Ph.D. |
2017 |
Targeting a Potassium Channel/Syntaxin Interaction Ameliorates Cell Death in Ischemic Stroke. |
|
2017 |
Pharmacokinetics and safety profile of single-dose administration of an estrogen receptor β-selective phytoestrogenic (phytoSERM) formulation in perimenopausal and postmenopausal women. |
Roberta Diaz Brinton, Ph.D |
2017 |
Fluorescent-labeled bioconjugates of the opioid peptides biphalin and DPDPE incorporating fluorescein-maleimide linkers. |
John M. Streicher, PhD |
2017 |
Role of Transporters in Central Nervous System Drug Delivery and Blood-Brain Barrier Protection: Relevance to Treatment of Stroke. |
Patrick T Ronaldson, PhD, FAAPS |
2017 |
Sex and Race Differences in the Association Between Statin Use and the Incidence of Alzheimer Disease. |
Roberta Diaz Brinton, Ph.D |
2017 |
Sonogashira diversification of unprotected halotryptophans, halotryptophan containing tripeptides; and generation of a new to nature bromo-natural product and its diversification in water |
Christopher Cartmell |
2017 |
Genetic and pharmacological antagonism of NK1 receptor prevents opiate abuse potential. |
Tally Largent-Milnes, PhD, Todd Vanderah, PhD |
2017 |
Heat-shock protein 90 (Hsp90) promotes opioid-induced anti-nociception by an ERK mitogen-activated protein kinase (MAPK) mechanism in mouse brain. |
John M. Streicher, PhD |
2017 |
Bone morphogenetic protein-9 increases the functional expression of organic anion transporting polypeptide 1a4 at the blood-brain barrier via the activin receptor-like kinase-1 receptor. |
Thomas P Davis, PhD, Patrick T Ronaldson, PhD, FAAPS |
2017 |
Evidence for benefit of statins to modify cognitive decline and risk in Alzheimer's disease. |
Roberta Diaz Brinton, Ph.D |
2017 |
Synthetic analogues of cyanobacterial alkaloid cylindrospermopsin and their toxicological activity. |
Christopher Cartmell |
2017 |
Angiostatic actions of capsicodendrin through selective inhibition of VEGFR2-mediated AKT signaling and disregulated autophagy. |
Nam Lee, Ph.D. |
2017 |
Blocking CRMP2 SUMOylation reverses neuropathic pain. |
Tally Largent-Milnes, PhD, Todd Vanderah, PhD |
2017 |
Synergistic attenuation of chronic pain using mu opioid and cannabinoid receptor 2 agonists. |
Mohab M. Ibrahim, PhD, MD, Tally Largent-Milnes, PhD, Todd Vanderah, PhD |
2017 |
Analgesic Properties of Opioid/NK1 Multitarget Ligands with Distinct in Vitro Profiles in Naive and Chronic Constriction Injury Mice. |
John M. Streicher, PhD |
2018 |
Loss of Blood-Brain Barrier Integrity in a KCl-Induced Model of Episodic Headache Enhances CNS Drug Delivery. |
Thomas P Davis, PhD, Erika Liktor-Busa, PhD, PharmD, Tally Largent-Milnes, PhD, Todd Vanderah, PhD |
2018 |
Peripherally restricted cannabinoid 1 receptor agonist as a novel analgesic in cancer-induced bone pain. |
Mohab M. Ibrahim, PhD, MD, Tally Largent-Milnes, PhD, Todd Vanderah, PhD |
2018 |
Blood-brain barrier dysfunction in ischemic stroke: targeting tight junctions and transporters for vascular protection. |
Patrick T Ronaldson, PhD, FAAPS |
2018 |
Continuous remote ischemic conditioning attenuates cognitive and motor deficits from moderate traumatic brain injury. |
Tally Largent-Milnes, PhD, Todd Vanderah, PhD |
2018 |
A Kappa Opioid Receptor Agonist Blocks Bone Cancer Pain Without Altering Bone Loss, Tumor Size, or Cancer Cell Proliferation in a Mouse Model of Cancer-Induced Bone Pain. |
Tally Largent-Milnes, PhD, John M. Streicher, PhD, Todd Vanderah, PhD |
2019 |
Neuroendocrine aging precedes perimenopause and is regulated by DNA methylation. |
Fei Yin, Ph.D. |
2019 |
Cdk5-mediated CRMP2 phosphorylation is necessary and sufficient for peripheral neuropathic pain. |
Tally Largent-Milnes, PhD, Todd Vanderah, PhD |